TY  - GEN
AU  - Sezai,Akira
AU  - Nakai,Tishiko
AU  - Hata,Mitsumasa
AU  - Yoshitake,Isamu
AU  - Shiono,Motomi
AU  - Kunimoto,Satoshi
AU  - Hirayama,Atsushi
TI  - Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study
SN  - 1097-685X
PY  - 2013///0110
KW  - Administration, Oral
KW  - Adrenergic beta-Antagonists
KW  - administration & dosage
KW  - Aged
KW  - Aged, 80 and over
KW  - Anti-Arrhythmia Agents
KW  - Anti-Inflammatory Agents
KW  - Antioxidants
KW  - Arginine
KW  - analogs & derivatives
KW  - Atrial Fibrillation
KW  - blood
KW  - Biomarkers
KW  - Bisoprolol
KW  - C-Reactive Protein
KW  - metabolism
KW  - Coronary Artery Bypass
KW  - adverse effects
KW  - Creatine Kinase, MB Form
KW  - Drug Administration Schedule
KW  - Fatty Acid Binding Protein 3
KW  - Fatty Acid-Binding Proteins
KW  - Female
KW  - Hemodynamics
KW  - drug effects
KW  - Humans
KW  - Infusions, Intravenous
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Morpholines
KW  - Natriuretic Peptide, Brain
KW  - Pilot Projects
KW  - Serum Amyloid P-Component
KW  - Single-Blind Method
KW  - Time Factors
KW  - Treatment Outcome
KW  - Troponin I
KW  - Urea
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jtcvs.2012.06.042
ER  -